Immune System Can Detect Disease During Pregnancy
By LabMedica International staff writers Posted on 13 Jan 2022 |

Image: The Bio-Plex 200 system is a suspension array system which offers protein and nucleic acid analysis and a reliable multiplex assay solution that permits analysis of up to 100 biomolecules in a single sample (Photo courtesy of Bio-Rad)
Pregnancy is a challenge for the mother's immune system from the outset. Half of the genes in the fetus are foreign to her body. The immune system has to strike a balance between tolerating the fetus and protecting the mother and fetus from infections. Throughout the pregnancy, an immunological balance takes place between mother and child.
Maternal serum cytokine profiling can be used to gain detailed information about maternal inflammatory status, fetal stress, and early signs of immunological disturbance. Immunological profiling by simultaneous measurement and analysis of multiple cytokines provides higher sensitivity and depicts ongoing inflammatory processes better than single cytokine measurements as cytokines comprise complex functional networks.
Clinical Scientists at the Norwegian University of Science and Technology (Trondheim, Norway) and their associates selected women with normal singleton pregnancies and were chosen from five different cohorts. Serum samples were collected between 2002 and 2015 at two hospitals in Trondheim, and between 2003 and 2012 at Haukeland University Hospital (Bergen, Norway).
The team performed cytokine profiling of 1,149 longitudinal serum samples from 707 pregnant women to map immunological changes from first trimester to term and beyond. The serum samples were analyzed for 27 cytokines (Bio-Plex Pro Human Cytokine 27-plex Assay) in single replicates using Luminex xMAP Technology on a Bio-Plex 200 System (Bio-Rad Laboratories, Hercules, CA, USA). High-sensitivity CRP (hsCRP) measurements in serum was obtained using Human CRP Quantikine kit (R&D Systems, Minneapolis, MN, USA). Some samples were analyzed for hsCRP using turbidimetric assay and measured at 571 nm by a Siemens Advia Chemistry XPT system (Siemens Healthineers, Erlangen, Germany).
The investigators reported that the serum levels of 22 cytokines and CRP followed diverse but characteristic trajectories throughout pregnancy, consistent with staged immunological adaptations. Eotaxin showed a particularly robust decrease throughout pregnancy. A strong surge in cytokine levels developed when pregnancies progressed beyond term and the increase was amplified as labor approached. Maternal obesity, smoking and pregnancies with large fetuses showed sustained increase in distinct cytokines throughout pregnancy. Multiparous women had increased cytokine levels in the first trimester compared to nulliparous women with higher cytokine levels in the third trimester. Fetal sex affected first trimester cytokine levels with increased levels in pregnancies with a female fetus.
Ann-Charlotte Iversen, PhD, a Professor of Molecular Biology and senior author of study, said, “A cytokine profile is a very sensitive measurement of the immune system, and now we have a better understanding of the immune system’s normal development in pregnancy and how it’s affected. Once we’ve mapped the changes that characterize various pregnancy complications, it will show us which abnormalities we should look for in order to detect disease development as early as possible. Having this sensitive a method will enable us to point out high-risk pregnancies so we can follow up the mother and fetus more closely. That’s our goal.”
The authors concluded that their findings unravel important immunological dynamics of pregnancy, demonstrate how both maternal and fetal factors influence maternal systemic cytokines, and serve as a comprehensive reference for cytokine profiles in normal pregnancies. The study was originally published on October 14, 2021 in the journal Frontiers in Immunology.
Related Links:
Norwegian University of Science and Technology
Haukeland University Hospital
Bio-Rad Laboratories
R&D Systems
Siemens Healthineers
Maternal serum cytokine profiling can be used to gain detailed information about maternal inflammatory status, fetal stress, and early signs of immunological disturbance. Immunological profiling by simultaneous measurement and analysis of multiple cytokines provides higher sensitivity and depicts ongoing inflammatory processes better than single cytokine measurements as cytokines comprise complex functional networks.
Clinical Scientists at the Norwegian University of Science and Technology (Trondheim, Norway) and their associates selected women with normal singleton pregnancies and were chosen from five different cohorts. Serum samples were collected between 2002 and 2015 at two hospitals in Trondheim, and between 2003 and 2012 at Haukeland University Hospital (Bergen, Norway).
The team performed cytokine profiling of 1,149 longitudinal serum samples from 707 pregnant women to map immunological changes from first trimester to term and beyond. The serum samples were analyzed for 27 cytokines (Bio-Plex Pro Human Cytokine 27-plex Assay) in single replicates using Luminex xMAP Technology on a Bio-Plex 200 System (Bio-Rad Laboratories, Hercules, CA, USA). High-sensitivity CRP (hsCRP) measurements in serum was obtained using Human CRP Quantikine kit (R&D Systems, Minneapolis, MN, USA). Some samples were analyzed for hsCRP using turbidimetric assay and measured at 571 nm by a Siemens Advia Chemistry XPT system (Siemens Healthineers, Erlangen, Germany).
The investigators reported that the serum levels of 22 cytokines and CRP followed diverse but characteristic trajectories throughout pregnancy, consistent with staged immunological adaptations. Eotaxin showed a particularly robust decrease throughout pregnancy. A strong surge in cytokine levels developed when pregnancies progressed beyond term and the increase was amplified as labor approached. Maternal obesity, smoking and pregnancies with large fetuses showed sustained increase in distinct cytokines throughout pregnancy. Multiparous women had increased cytokine levels in the first trimester compared to nulliparous women with higher cytokine levels in the third trimester. Fetal sex affected first trimester cytokine levels with increased levels in pregnancies with a female fetus.
Ann-Charlotte Iversen, PhD, a Professor of Molecular Biology and senior author of study, said, “A cytokine profile is a very sensitive measurement of the immune system, and now we have a better understanding of the immune system’s normal development in pregnancy and how it’s affected. Once we’ve mapped the changes that characterize various pregnancy complications, it will show us which abnormalities we should look for in order to detect disease development as early as possible. Having this sensitive a method will enable us to point out high-risk pregnancies so we can follow up the mother and fetus more closely. That’s our goal.”
The authors concluded that their findings unravel important immunological dynamics of pregnancy, demonstrate how both maternal and fetal factors influence maternal systemic cytokines, and serve as a comprehensive reference for cytokine profiles in normal pregnancies. The study was originally published on October 14, 2021 in the journal Frontiers in Immunology.
Related Links:
Norwegian University of Science and Technology
Haukeland University Hospital
Bio-Rad Laboratories
R&D Systems
Siemens Healthineers
Latest Immunology News
- Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
- Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
- Post-Treatment Blood Test Could Inform Future Cancer Therapy Decisions
- Cerebrospinal Fluid Test Predicts Dangerous Side Effect of Cancer Treatment
- New Test Measures Preterm Infant Immunity Using Only Two Drops of Blood
- Simple Blood Test Could Help Choose Better Treatments for Patients with Recurrent Endometrial Cancer
- Novel Analytical Method Tracks Progression of Autoimmune Diseases
- 3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response
- Blood Test for Fungal Infections Could End Invasive Tissue Biopsies
- Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies
- New Discovery in Blood Immune Cells Paves Way for Parkinson's Disease Diagnostic Test
- AI Tool Uses Routine Blood Tests to Predict Immunotherapy Response for Various Cancers
- Blood Test Can Predict How Long Vaccine Immunity Will Last
- Microfluidic Chip-Based Device to Measure Viral Immunity
Channels
Clinical Chemistry
view channel
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Novel Autoantibody Against DAGLA Discovered in Cerebellitis
Autoimmune cerebellar ataxias are strongly disabling disorders characterized by an impaired ability to coordinate muscle movement. Cerebellar autoantibodies serve as useful biomarkers to support rapid... Read more
Gene-Based Blood Test Accurately Predicts Tumor Recurrence of Advanced Skin Cancer
Melanoma, an aggressive form of skin cancer, becomes extremely difficult to treat once it spreads to other parts of the body. For patients with metastatic melanoma tumors that cannot be surgically removed... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreMicrobiology
view channel
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
Novel UV and Machine Learning-Aided Method Detects Microbial Contamination in Cell Cultures
Cell therapy holds great potential in treating diseases such as cancers, inflammatory conditions, and chronic degenerative disorders by manipulating or replacing cells to restore function or combat disease.... Read more
New Error-Corrected Method to Help Detect Cancer from Blood Samples Alone
"Liquid biopsy" technology, which relies on blood tests for early cancer detection and monitoring cancer burden in patients, has the potential to transform cancer care. However, detecting the mutational... Read more
"Metal Detector" Algorithm Hunts Down Vulnerable Tumors
Scientists have developed an algorithm capable of functioning as a "metal detector" to identify vulnerable tumors, marking a significant advancement in personalized cancer treatment. This breakthrough... Read more
Novel Technique Uses ‘Sugar’ Signatures to Identify and Classify Pancreatic Cancer Cell Subtypes
Pancreatic cancer is often asymptomatic in its early stages, making it difficult to detect until it has progressed. Consequently, only 15% of pancreatic cancers are diagnosed early enough to allow for... Read moreTechnology
view channel
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more